These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34365863)

  • 21. Guselkumab in the treatment of concomitant hidradenitis suppurativa, psoriasis, and Crohn's disease.
    Berman HS; Villa NM; Shi VY; Hsiao JL
    J Dermatolog Treat; 2021 Mar; 32(2):261-263. PubMed ID: 31389737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report.
    Thorlacius L; Theut Riis P; Jemec GBE
    Br J Dermatol; 2018 Jul; 179(1):182-185. PubMed ID: 28654150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis.
    Shih T; Lee K; Grogan T; De DR; Shi VY; Hsiao JL
    Dermatol Ther; 2022 Sep; 35(9):e15691. PubMed ID: 35790062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.
    Tas-Aygar G; Gonul M; Ozcan I; Ayli MD; Ertoy-Baydar D
    Dermatol Ther; 2020 Nov; 33(6):e14205. PubMed ID: 32829493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches.
    Tampouratzi E; Kanni T; Katsantonis J; Douvali T
    F1000Res; 2019; 8():2002. PubMed ID: 33456757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa.
    Malvaso D; Calabrese L; Chiricozzi A; Antonelli F; Coscarella G; Rubegni P; Peris K
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.
    Del Duca E; Morelli P; Bennardo L; Di Raimondo C; Nisticò SP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
    Prussick L; Rothstein B; Joshipura D; Saraiya A; Turkowski Y; Abdat R; Alomran A; Zancanaro P; Kachuk C; Dumont N; Gottlieb AB; Rosmarin D
    Br J Dermatol; 2019 Sep; 181(3):609-611. PubMed ID: 30801662
    [No Abstract]   [Full Text] [Related]  

  • 29. Target molecules for future hidradenitis suppurativa treatment.
    Zouboulis CC; Frew JW; Giamarellos-Bourboulis EJ; Jemec GBE; Del Marmol V; Marzano AV; Nikolakis G; Sayed CJ; Tzellos T; Wolk K; Prens EP
    Exp Dermatol; 2021 Jun; 30 Suppl 1():8-17. PubMed ID: 34085329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigational drugs in clinical trials for Hidradenitis Suppurativa.
    Theut Riis P; Thorlacius LR; Jemec GB
    Expert Opin Investig Drugs; 2018 Jan; 27(1):43-53. PubMed ID: 29188733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of hidradenitis suppurativa with secukinumab in a patient with ankylosing spondylitis and Familial Mediterranean Fever.
    Unal Enginar A; Gundogdu M
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):19-21. PubMed ID: 34508267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis.
    Thomas LW; Lee EB; Wu JJ
    J Dermatolog Treat; 2019 Mar; 30(2):110-116. PubMed ID: 29737896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of hidradenitis suppurativa with tumour necrosis factor-alpha inhibitors.
    Haslund P; Lee RA; Jemec GB
    Acta Derm Venereol; 2009 Nov; 89(6):595-600. PubMed ID: 19997689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis.
    Tada Y; Watanabe R; Noma H; Kanai Y; Nomura T; Kaneko K
    J Dermatol Sci; 2020 Jul; 99(1):53-61. PubMed ID: 32600737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial.
    Kimball AB; Kerdel F; Adams D; Mrowietz U; Gelfand JM; Gniadecki R; Prens EP; Schlessinger J; Zouboulis CC; van der Zee HH; Rosenfeld M; Mulani P; Gu Y; Paulson S; Okun M; Jemec GB
    Ann Intern Med; 2012 Dec; 157(12):846-55. PubMed ID: 23247938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Promising Therapeutic Targets in Hidradenitis Suppurativa: A Critical Evaluation of Mechanistic and Clinical Relevance.
    Frew JW; Marzano AV; Wolk K; Join-Lambert O; Alavi A; Lowes MA; Piguet V
    J Invest Dermatol; 2021 Feb; 141(2):316-324.e2. PubMed ID: 32919760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis.
    Egeberg A; Andersen YMF; Halling-Overgaard AS; Alignahi F; Thyssen JP; Burge R; Mallbris L
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):39-46. PubMed ID: 31465593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biologic Use in Pediatric Patients With Hidradenitis Suppurativa: A Systematic Review.
    Sachdeva M; Kim P; Mufti A; Maliyar K; Sibbald C; Alavi A
    J Cutan Med Surg; 2022; 26(2):176-180. PubMed ID: 34587768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.